AVALA RES
Research AVALA RES (CVJ) on Bullrun: market cap EUR 830.30K, P/E 0.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCVJ
- ExchangeF
- CountryAustralia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 830.30K
- P/E0.1
- Financial periodFY2024
- RevenueEUR 15.37M
- Revenue growth11.6%
- Net income-EUR 51.24M
- Free cash flow-EUR 17.69M
- Gross margin100.0%
Valuation Snapshot
latest market cap is EUR 830.30K; P/E is 0.1.
About AVALA RES
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
Frequently asked questions
What is AVALA RES's market cap?
AVALA RES's market capitalization is EUR 830.30K.
What is AVALA RES's P/E ratio?
AVALA RES's price-to-earnings (P/E) ratio is 0.1.
What does AVALA RES do?
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids.